CalciMedica Inc expected to post a loss of 35 cents a share - Earnings Preview

Calcimedica

24/03/2025 12:33

CalciMedica Inc CALC.OQ CALC.O is expected to show no change in quarterly revenue when it reports  results on March 26 (estimated) for the period ending December 31 2024

​LSEG's mean analyst estimate for CalciMedica Inc is for a loss of 35 cents per share.

The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 4 "strong buy" or "buy," no "hold" and no "sell" or "strong sell."

The mean earnings estimate of analysts was unchanged in the last three months. ​

Wall Street's median 12-month price target for CalciMedica Inc is $15.50​, above​ its last closing price of $2.01. ​​​

Previous quarterly performance (using preferred earnings measure in US dollars). ​

QUARTER ENDING
STARMINESMARTESTIMATE®
LSEG IBES ESTIMATE
ACTUAL
BEAT, MET, MISSED
SURPRISE %
Sep. 30 2024
-0.50
-0.50
-0.50
Met
-0.7
Jun. 30 2024
-0.52
-0.53
-0.36
Beat
31.6
Mar. 31 2024
-0.69
-0.67
0.01
Beat
101.5​
Dec. 31 2023
-0.72
-0.87
-0.23
Beat
73.6
​​Sep. 30 2023
-1.14
-1.14
-0.82
Beat
28.1
Jun. 30 2023
-1.05
-1.04
-1.11
Missed
-6.2​
Mar. 31 2023
-0.73
-0.73
-23.43
Missed
-3,109.6

This summary was machine generated March 24 at 12:32 GMT.  All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)